Sign in
CompletedNo phase

TVMR With the Innovalve System Trial - Pilot in Georgia

Key facts

Who runs it
Edwards Lifesciences
Where
Georgia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
11 people enrolled
Started
1 Dec 2021
Ended
1 Jan 2025
Type of study
Interventional
Treatments tested
  • Innovalve MR system
Record updated
23 April 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Clinically significant, symptomatic mitral regurgitation
  • High risk for open-heart surgery
  • Meets anatomical criteria

Who cannot take part

  • Unsuitable anatomy
  • Patient is inoperable
  • EF<25%

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Study to evaluate the safety and performance of the Innovalve mitral valve replacement system

The group in the trial

  • Innovalve TMVR SystemTreatment being tested

    MV replacement with Innovalve MR system

    Treatment: Innovalve MR system

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
23 April 2025